Target blood pressure and cardiovascular risk
- PMID: 28839978
- PMCID: PMC5543006
- DOI: 10.21037/jtd.2017.06.125
Target blood pressure and cardiovascular risk
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment in
-
Target blood pressure in high risk cardiovascular patients.J Thorac Dis. 2017 Sep;9(9):E877-E878. doi: 10.21037/jtd.2017.08.88. J Thorac Dis. 2017. PMID: 29221367 Free PMC article. No abstract available.
Comment on
-
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.Lancet. 2017 Jun 3;389(10085):2226-2237. doi: 10.1016/S0140-6736(17)30754-7. Epub 2017 Apr 5. Lancet. 2017. PMID: 28390695
References
-
- Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Yusuf S, Teo K, et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008;372:1174-83. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources